Disciplined Investments’s Veracyte VCYT Stock Holding History

Disciplined Investments’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3	Closed	-$76	–	1482
2023 Q2	$76	Hold	3	–	–	﹤0.01%	1631
2023 Q1	$67	Buy	+3	New	+$73	﹤0.01%	1614
2022 Q2	–	Sell	-3	Closed	–	–	1644
2022 Q1	$0	Buy	+3	New	+$86	﹤0.01%	1638

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Disciplined Investments's VCYT Position: Q3 2023 in Review

Disciplined Investments sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 3 shares — an estimated $76 sold.

Disciplined Investments first reported a position in VCYT in Q1 2022 and held it in 3 quarters. The position peaked at $76 in Q2 2023. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

Disciplined Investments reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
Disciplined Investments sold 3 Veracyte shares in Q3 2023, an estimated $76.
Disciplined Investments first reported a position in Veracyte in Q1 2022 and held it in 3 quarters.
Disciplined Investments's Veracyte position peaked at $76 in Q2 2023.
236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.